Used as a selective allosteric modulator of the metabotropic glutamate receptor 2 (mGluR2), it enhances receptor activity in response to glutamate. This property makes it valuable in neuroscience research, particularly in studies related to anxiety, schizophrenia, and other central nervous system disorders. It helps investigators understand glutamatergic signaling pathways and evaluate potential therapeutic targets without directly activating the receptor. Its role as a research tool supports the development of novel anxiolytic and antipsychotic drugs with potentially fewer side effects than current treatments.